Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$1.43 +0.05 (+3.65%)
As of: Nov 11, 2026 · 2:24 PM EST

Kiora Pharmaceuticals (KPRX) Return on Equity [ROE] (2015 - 2026)

Updated

Kiora Pharmaceuticals (KPRX) reported Return on Equity [ROE] of -71.25% for Q2 2026, up 14.53 percentage points from -85.77% a year earlier and up 2.22 percentage points from the prior quarter.

Analysis

Kiora Pharmaceuticals (KPRX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends

For FY2025, Kiora Pharmaceuticals posted Return on Equity [ROE] of -51.65%, down 96.55 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of +32.27 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at 44.90% in FY2024 (+336.82 pp), -291.92% in FY2023 (-82.84 pp), -209.09% in FY2022 (-95.79 pp) and -113.30% in FY2021 (-29.37 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -297.59% in Q4 2023 and a high of 0.06% in Q3 2024.
  • Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +35.58 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 282.98 percentage points); the low point was Q3 2022 (a drop of 154.94 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -73.47% (Q1 2026), -56.14% (Q4 2025) and -57.48% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Kiora Pharmaceuticals 8.53 Mn -58.79 Mn - -71.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71.43%
Mar 31, 2026 -73.13%
Dec 31, 2025 -56.05%
Sep 30, 2025 -39.12%
Jun 30, 2025 -52.29%
Mar 31, 2025 -48.86%
Dec 31, 2024 12.53%
Sep 30, 2024 18.19%
Jun 30, 2024 9.35%
Mar 31, 2024 13.45%
Dec 31, 2023 -176.08%
Sep 30, 2023 -117.23%
Jun 30, 2023 -101.70%
Mar 31, 2023 -111.71%
Dec 31, 2022 -124.77%
Sep 30, 2022 -181.20%
Jun 30, 2022 -153.77%
Mar 31, 2022 -119.16%
Dec 31, 2021 -86.80%
Sep 30, 2021 -57.73%
API Access

Kiora Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KPRX&period=max&api_key=YOUR_API_KEY